{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T22:02:53Z","timestamp":1764194573024,"version":"3.37.3"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>\u2002<\/jats:title><\/jats:sec><jats:sec><jats:title>OBJECTIVES<\/jats:title><jats:p>The aim of this study was to evaluate the clinical and haemodynamic results after implantation of the Trifecta bioprosthesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>This study is a retrospective analysis of all patients undergoing Trifecta aortic valve replacement between 01 January 2012 and 31 December 2017 at the Ghent University Hospital. Univariable and multivariable analyses were performed to identify predictors of valve- and procedure-related complications and mortality. The haemodynamic performance was analysed by longitudinal Doppler echocardiography.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>The mean age of the 182 patients was 77 [standard deviation (SD): 5.5] years; 54.9% were women. The mean follow-up was 39.8 (SD: 24.3) months. Overall survival at 1 and 5\u2009years was 86% (SD: 3%) and 68% (SD: 4%), respectively, and overall freedom from structural valve deterioration was 100% and 98% at 1 and 5\u2009years, respectively. There was no valve thrombosis nor early endocarditis. Urgent surgery was the only risk factor for early mortality in the multivariable analysis [P\u2009=\u20090.009, odds ratio 0.06, 95% confidence interval (CI) 0.01\u20130.5]. Preoperative atrial fibrillation was the most important predictor of late mortality (P\u2009=\u20090.001, hazard ratio 3.68, 95% CI 1.65\u20138.21). The average peak gradients were stable from discharge up to 1 and 5\u2009years postoperatively [15 (SD: 6) and 17 (SD: 8) mmHg].<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>These results confirm the excellent clinical performance of the Trifecta valve, particularly in an elderly age group. Through the 7-year follow-up period, low transvalvular gradients persisted, and only a few patients needed reoperation. Although structural valve degeneration occurred rarely, it was unrelated to valve size or age at implantation; therefore, further long-term follow-up remains mandatory.<\/jats:p><\/jats:sec>","DOI":"10.1093\/icvts\/ivab205","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T11:16:17Z","timestamp":1626347777000},"page":"16-25","source":"Crossref","is-referenced-by-count":5,"title":["Mid-term clinical and haemodynamic results after aortic valve replacement with the Trifecta bioprosthesis"],"prefix":"10.1093","volume":"34","author":[{"given":"Augustijn","family":"Mortel\u00e9","sequence":"first","affiliation":[{"name":"Ghent University, Faculty of Medicine and Health Sciences , Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9198-6829","authenticated-orcid":false,"given":"Alexander","family":"Dereu","sequence":"additional","affiliation":[{"name":"Ghent University, Faculty of Medicine and Health Sciences , Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Bov\u00e9","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, University Hospital Ghent , Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrien","family":"Fran\u00e7ois","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, University Hospital Ghent , Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jtcvs.2016.07.080","article-title":"Mid-term durability of the Trifecta bioprosthesis for aortic valve replacement","volume":"153","author":"Anselmi","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.117.030729","article-title":"Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves","volume":"137","author":"Dvir","year":"2018","journal-title":"Circulation"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jtcvs.2008.08.015","article-title":"Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database","volume":"137","author":"Brown","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jtcvs.2012.12.087","article-title":"The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study","volume":"147","author":"Bavaria","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.athoracsur.2019.10.060","article-title":"Reintervention after aortic valve replacement: comparison of 3 aortic bioprostheses","volume":"110","author":"Lam","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.athoracsur.2019.06.032","article-title":"Early structural valve degeneration of Trifecta bioprosthesis","volume":"109","author":"Fukuhara","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1111\/jocs.15062","article-title":"Six-year follow-up of aortic valve reoperation rates: Carpentier-Edwards Perimount versus St. Jude Medical Trifecta","volume":"35","author":"Stubeda","year":"2020","journal-title":"J Card Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.athoracsur.2019.12.071","article-title":"Trifecta versus Perimount Magna ease aortic valve prostheses","volume":"110","author":"Biancari","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jtcvs.2007.12.002","article-title":"Guidelines for reporting mortality and morbidity after cardiac valve interventions","volume":"135","author":"Akins","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.athoracsur.2017.05.076","article-title":"The prevalence of patient-prosthesis mismatch can be reduced using the Trifecta aortic prosthesis","volume":"105","author":"Hernandez-Vaquero","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.athoracsur.2018.10.063","article-title":"Trifecta aortic bioprosthesis: midterm results in 1,953 patients from a single center","volume":"107","author":"Kilic","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.jtcvs.2013.12.051","article-title":"Comparison of early hemodynamic performance of 3 aortic valve bioprostheses","volume":"148","author":"Ugur","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jtcvs.2016.09.089","article-title":"Midterm, multicenter clinical and hemodynamic results for the Trifecta aortic pericardial valve","volume":"153","author":"Goldman","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/icvts\/ivs460","article-title":"Clinical and echocardiographic outcomes after implantation of the Trifecta aortic bioprosthesis: an initial single-centre experience","volume":"16","author":"Dell'Aquila","year":"2013","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/ejcts\/ezv411","article-title":"Early haemodynamic performance of a latest generation supra-annular aortic bioprosthesis: experience from a large single-centre series","volume":"49","author":"Deutsch","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12471-011-0238-6","article-title":"Long-term outcomes of isolated aortic valve replacement and concomitant AVR and coronary artery bypass grafting","volume":"20","author":"de Waard","year":"2012","journal-title":"Neth Heart J"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jacc.2012.11.050","article-title":"Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration)","volume":"61","author":"Chieffo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023032019562650400_","first-page":"325","article-title":"Early in vivo hemodynamic comparison of supra-annular aortic bioprostheses: Trifecta versus Perimount Magna ease","volume":"23","author":"Modi","year":"2014","journal-title":"J Heart Valve Dis"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1253\/circj.CJ-14-0990","article-title":"Hemodynamic performance and durability of mosaic bioprostheses for aortic valve replacement, up to 13 years","volume":"79","author":"Matsumoto","year":"2015","journal-title":"Circ J"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/icvts\/ivv363","article-title":"Haemodynamic performance of the small supra-annular Trifecta bioprosthesis: results from a French multicentre study","volume":"22","author":"Fouquet","year":"2016","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0003-4975(02)03445-8","article-title":"Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis","volume":"73","author":"Banbury","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ejcts.2010.11.015","article-title":"Hemodynamic performance of the Medtronic Mosaic and Perimount Magna aortic bioprostheses: five-year results of a prospectively randomized study","volume":"39","author":"Dalmau","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1556984519826430","article-title":"Aortic valve replacement in elderly patients with small aortic annulus: results with three different bioprostheses","volume":"14","author":"Chiariello","year":"2019","journal-title":"Innovations (Phila)"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.jtcvs.2014.03.018","article-title":"Early failures of Trifecta aortic bioprosthesis","volume":"148","author":"Campisi","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jtcvs.2017.05.044","article-title":"Early Trifecta valve failure: report of a cluster of cases from a tertiary care referral center","volume":"154","author":"Kalra","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/icvts\/ivu384","article-title":"Leaflet tear in a Trifecta aortic bioprosthesis 34 months after implantation","volume":"20","author":"Pi\u00f1\u00f3n","year":"2015","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/jocs.12778","article-title":"Early failure of Trifecta bioprosthesis in the aortic position","volume":"31","author":"Yoshida","year":"2016","journal-title":"J Card Surg"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.hlc.2017.03.157","article-title":"Acute structural failure of the Trifecta aortic valve bioprosthesis","volume":"26","author":"Zhu","year":"2017","journal-title":"Heart Lung Circ"},{"key":"2023032019562650400_","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jtcvs.2017.04.034","article-title":"Early degeneration of the St Jude Medical Trifecta bioprosthetic aortic valve: a problem of the leaflets or of the stent?","volume":"154","author":"Santarpino","year":"2017","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Interactive CardioVascular and Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/icvts\/article-pdf\/34\/1\/16\/49571588\/ivab205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/icvts\/article-pdf\/34\/1\/16\/49571588\/ivab205.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T02:49:07Z","timestamp":1699238947000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/icvts\/article\/34\/1\/16\/6347639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/icvts\/ivab205","relation":{},"ISSN":["1569-9285"],"issn-type":[{"type":"electronic","value":"1569-9285"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,8,11]]}}}